×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Pfizer names six finalists in $55 mil Lipitor review

Published on .

Pfizer has picked six finalists to compete for the $55 million account for its cholesterol-lowering drug Lipitor. Cline, Davis & Mann; Deutsch; Gotham; Kirshenbaum Bond & Partners; Merkley Newman Harty; and Messner Vetere Berger McNamee Schmetterer/Euro RSCG, all New York, will make presentations at the beginning of December. Consultant on the review is Advice & Advisors.

Copyright October 2000, Crain Communications Inc.

In this article:
Most Popular